- Home
- BLFS vs INVA Comparison
BLFS vs INVA Comparison
Compare BLFS & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- INVA
- Stock Information
- Founded
- BLFS 1987
- INVA 1996
- Country
- BLFS United States
- INVA United States
- Employees
- BLFS N/A
- INVA N/A
- Industry
- BLFS Medical/Dental Instruments
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- BLFS Health Care
- INVA Health Care
- Exchange
- BLFS Nasdaq
- INVA Nasdaq
- Market Cap
- BLFS 1.2B
- INVA 1.3B
- IPO Year
- BLFS 1989
- INVA 2004
- Fundamental
- Price
- BLFS $26.46
- INVA $20.48
- Analyst Decision
- BLFS Strong Buy
- INVA Strong Buy
- Analyst Count
- BLFS 7
- INVA 4
- Target Price
- BLFS $30.86
- INVA $40.25
- AVG Volume (30 Days)
- BLFS 606.5K
- INVA 760.2K
- Earning Date
- BLFS 08-07-2025
- INVA 11-05-2025
- Dividend Yield
- BLFS N/A
- INVA N/A
- EPS Growth
- BLFS N/A
- INVA N/A
- EPS
- BLFS N/A
- INVA 0.53
- Revenue
- BLFS $93,468,000.00
- INVA $370,229,000.00
- Revenue This Year
- BLFS $26.07
- INVA $8.17
- Revenue Next Year
- BLFS $16.86
- INVA $12.06
- P/E Ratio
- BLFS N/A
- INVA $39.25
- Revenue Growth
- BLFS 68.16
- INVA 12.02
- 52 Week Low
- BLFS $19.10
- INVA $16.67
- 52 Week High
- BLFS $29.55
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- BLFS 66.89
- INVA 56.42
- Support Level
- BLFS $24.64
- INVA $19.60
- Resistance Level
- BLFS $26.29
- INVA $21.11
- Average True Range (ATR)
- BLFS 0.80
- INVA 0.51
- MACD
- BLFS 0.03
- INVA 0.05
- Stochastic Oscillator
- BLFS 98.13
- INVA 57.89
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.